Search Results - "Sabloak, Thwisha"

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer by Kung, Che-Pei, Cottrell, Kyle A., Ryu, Sua, Bramel, Emily R., Kladney, Raleigh D., Bao, Emily A., Freeman, Eric C., Sabloak, Thwisha, Maggi Jr, Leonard, Weber, Jason D.

“…Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted…”
Get full text

Antepartum Emergency Department Use and Associations with Maternal and Neonatal Outcomes in a Large Hospital System by Sabloak, Thwisha, Yee, Lynn M, Feinglass, Joe

“…Objectives: Prenatal care in the United States has remained unchanged for decades, with pregnant patients often experiencing high rates of hospital emergency…”
Get full text

3174 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1 by Kung, Che-Pei, Bross, Emily, Bramel, Emily, Freeman, Eric, Sabloak, Thwisha, Kuzmicki, Catherine, Benjamin, Mike, Maggi, Leonard, Weber, Jason

“…OBJECTIVES/SPECIFIC AIMS: Triple-negative breast cancer (TNBC) accounts for one-fifth of the breast cancer patient population. The heterogeneous nature of TNBC…”
Get full text

Intimate Partner Violence Detected during Abortion-Related Visits: A Systematic Review of Screenings and Interventions by Sabloak, Thwisha, Ryan, Isa, Nahi, Skylar, Eucalitto, Patrick, Simon, Melissa A, Premkumar, Ashish

“…To perform a systematic review of screening tools and interventions focused on reducing adverse health outcomes associated with intimate partner violence (IPV)…”
Get more information

Abstract P4-08-03: Tumor suppressors p53 and ARF control ADAR1-driven tumorigenicity in triple negative breast cancer by Kung, Che-Pei, Kuzmicki, Catherine E, Bross, Emily A, Ryu, Sua, Freeman, Eric, Sabloak, Thwisha, Bramel, Emily R, Maggi, Leonard B, Weber, Jason D

“…Abstract Research Overview and Objective Triple-negative breast cancer (TNBC) accounts for one-fifth of the breast cancer patient population. The heterogeneous…”
Get full text

Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer by Kung, Che-Pei, Cottrell, Kyle A., Ryu, Sua, Bramel, Emily R., Kladney, Raleigh D., Bao, Emily A., Freeman, Eric C., Sabloak, Thwisha, Maggi, Leonard, Weber, Jason D.

“…A Correction to this paper has been published: https://doi.org/10.1038/s41388-021-01669-w…”
Get full text